Related Experiment Video

Updated: Aug 29, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

[Immuno-bacteriological characteristics of septic shock in children of early age]

Kh K Nurmukhamedov

    Klinichna Khirurhiia
    |December 11, 2003
    PubMed

    Insights

    Gram-negative bacteria dominate in pediatric septic shock (SS). Treatment with medical plasmapheresis and immunoglobulin improved immune factors and patient outcomes.

    Area of Science:

    • Pediatric bacteriology
    • Immunology
    • Critical care medicine

    Context:

    • Septic shock (SS) in young children presents a significant clinical challenge.
    • Bacteriological investigations reveal a prevalence of gram-negative, conditionally pathogenic microorganisms.
    • Initial stages show increased lipid peroxidation and suppressed immune responses.

    Purpose:

    • To investigate the microbiological landscape in pediatric septic shock.
    • To evaluate the impact of combined plasmapheresis and immunoglobulin therapy on immune factors and disease progression.

    Summary:

    • Gram-negative bacteria are predominant in early-age children experiencing generalized septic state and septic shock.
    • Increased intensity of lipid peroxidation (POL) and suppressed cellular and humoral immunity are observed.
    • Therapeutic application of medical plasmapheresis and immunoglobulin demonstrates a positive influence on homeostasis.

    Impact:

    • Combined therapy promotes a favorable disease course in pediatric septic shock.
    • This treatment approach aids in the prevention of severe complications.
    • Highlights the importance of targeted antimicrobial and immunomodulatory strategies in pediatric critical care.

    Related Concept Videos

    Bacterial Meningitis I: Introduction01:22

    Bacterial Meningitis I: Introduction

    Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
    Bacterial Meningitis II: Pathophysiology01:26

    Bacterial Meningitis II: Pathophysiology

    Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
    Bacterial Meningitis01:24

    Bacterial Meningitis

    Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
    Bacterial Gastroenteritis01:18

    Bacterial Gastroenteritis

    Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
    Development of Immunocompetence01:22

    Development of Immunocompetence

    The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
    The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
    Subsequent T...